Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists

Thrombosis Research

Volumn 101, Issue 2, 2001, Pages 53-64

  Dickfeld, Timm ^a   Ruf, Andreas ^b   Pogatsa Murray, Gisela ^a   Muller, Iris ^a   Engelmann, Bernd ^c   Taubitz, Winfried ^a   Fischer, Jorg ^a   Meier, Oliver ^a   Gawaz, Meinrad ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Klinikum Karlsruhe GGmbH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aggregation; GPIIb IIIa inhibitors; Intrinsic activity; LIBS induction; Platelets; Procoagulant activity

Indexed keywords

4 [[3 [4 [IMINO[(METHOXYCARBONYL)AMINO]METHYL]PHENYL] 2 OXO 5 OXAZOLIDINYL]METHYL] 1 PIPERAZINEACETIC ACID ETHYL ESTER; ABCIXIMAB; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTITHROMBOCYTIC AGENT; EPTIFIBATIDE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; LAMIFIBAN; MONOCLONAL ANTIBODY; PADGEM PROTEIN; THROMBIN; THROMBOPLASTIN; TIROFIBAN; YM 337;

ACUTE HEART FAILURE; ANIMAL CELL; ARTICLE; BINDING SITE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FLOW CYTOMETRY; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; TREATMENT OUTCOME;

ANIMALS; BINDING SITES; BLOOD PLATELETS; CHO CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; LIGANDS; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SECRETORY VESICLES; THROMBIN; TRANSFECTION;

EID: 0035862627     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00385-6     Document Type: Article

References (33)

1. Pathology of arterial thrombosis
2. Collaborative overview of randomised trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
3. Platelets in health and disease: Platelet GPIIb/IIIa structure and function: Recent advances in antiplatelet therapy
4. Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy
5. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine
6. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease
7. The platelet membrane glycoprotein IIb-IIIa complex
8. Cellular adhesion: GPIIb-IIIa as a prototypic adhesion receptor
9. Platelet integrins
10. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies
11. Evaluation of a GPIIb/IIIa antagonist YM 337 in a primate model of middle cerebral artery thrombosis
12. Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa
13. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
14. Randomized placebo-controlled trial of the effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT II
15. Ligand bridging mediates integrin αIIbβ3 (platelet GPIIb-IIIa) dependent homotypic and heterotypic cell-cell interactions
16. Effects of ATP on ligand recognition of platelet fibrinogen receptor on GPIIb-IIIa
17. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement
18. Evaluation of platelet membrane glycoproteins in coronary artery disease: Consequences for diagnosis and therapy
19. The procoagulant activity of red cells from patients with β-thalassemia major correlates with in-vivo platelet activation
20. Ligands activate integrin βIIbβ3 (platelet GPIIb-IIIa)
21. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (αIIbβ3) inhibitors
22. Platelet-dependent thrombin generation after in vitro fibrinolytic treatment
23. 2+ signaling
24. Molecular mechanisms of platelet activation
25. Mechanisms involved in platelet procoagulant response
26. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane: Studies in Scott syndrome: An isolated defect in platelet procoagulant activity
27. Platelet glycoprotein IIb-IIIa antagonists
28. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody
29. Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet rich plasma from patients
30. Effect of SR 121566A, a potent GPIIb/IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo
31. Acute profound thrombocytopenia after c7E3 FAB therapy
32. Specific platelet mediators and unstable coronary artery lesions: Experimental evidence and potential clinical implications
33. Functional relevance of the expression of ligand-induced binding sites in the response to platelet GPIIb/IIIa antagonists in vivo